A 2005 study [104] on homocysteine junction enzyme expression across various leukemia types established CBS expression levels, noting in the AML HL-60 TB line, CBS was not upregulated, with protein levels closely matching mRNA levels [104]. Here, CBS is linked to acute myeloid leukemia.